Selective Serotonin Reuptake Inhibitor-Associated Intracranial Hemorrhage: Drug-Specific Risk Patterns and Patient-Level Modifiers
Background: Selective serotonin reuptake inhibitors (SSRIs) are among the most commonly prescribed antidepressants and are generally considered safe. However, emerging data suggest a potential association with intracranial hemorrhage (ICH), especially among elderly patients and those on anticoagulat...
Saved in:
| Main Authors: | Josef Yayan, Kurt Rasche |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Neurology International |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2035-8377/17/7/111 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective Serotonin Reuptake Inhibitors and Risk of Gastrointesinal Bleeding In Dyspepsia: An Evidence-Based Case Report
by: Hamzah Shatri, et al.
Published: (2023-11-01) -
Selective serotonin reuptake inhibitors and spermatogenesis
by: M. N. Korshunov, et al.
Published: (2021-07-01) -
Drug-induced interstitial lung disease: a pharmacovigilance study of twelve immunomodulatory and antineoplastic agents
by: Josef Yayan, et al.
Published: (2025-07-01) -
Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021-05-01) -
Depressive disorders in cardiology practice : Diagnosis and treatment
by: F. Yu. Kopylov
Published: (2014-07-01)